Developmental Pilot of Support Groups for Caregivers of Children With DLD

April 10, 2026 updated by: University of Delaware
The purpose of this study is to test a new support group curriculum that we designed to support parents of children with Developmental Language Disorder (DLD).

Study Overview

Status

Enrolling by invitation

Intervention / Treatment

Detailed Description

After completing the informed consent process and eligibility has been verified, participants will complete parenting questionnaires. They will then be asked to attend 8-10 weekly support group meetings with other participants. Support group meetings are held remotely. After each meeting, participants will be asked to complete a brief questionnaire to learn about their experiences. After the final support group meeting, participants will be asked to complete the same parenting questionnaires as at study initiation. Participants will also be asked to complete a focus group with other support group attendees to share about their experiences in the group.

Study Type

Interventional

Enrollment (Estimated)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Delaware
      • Newark, Delaware, United States, 19713
        • University of Delaware

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Caregiver of an elementary aged (5-12 year old) child with a lab-confirmed diagnosis of DLD

Exclusion Criteria:

  • Not able to participate via teletherapy in a support group delivered in English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Developmental Pilot for Support Groups
Participants will join a teletherapy delivered support group for caregivers of children with DLD. They will attend 8-10 weekly support group meetings and provide feedback on the meeting content and format so that we can revise the materials and evaluate early efficacy prior to a larger in person pilot.
A manualized support group for families who care for a child with developmental language disorder (DLD)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualitative interviews with participants
Time Frame: up to 2 weeks after intervention
Focus group and/or one-on-one interviews with support group participants
up to 2 weeks after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Survey on Knowledge Seeking Behaviors
Time Frame: up to 4 weeks before and 2 weeks after intervention

We will use a survey developed by Darefsky (2022, adapted from (Al-Daihani & Al-Ateeqi, 2015). The survey consists of 9 total questions, of which there are two yes/no items, two multiple choice items, and four Likert scale items.

This measure is not scored in a way that results in minimum or maximum scores, or outcomes. This measure is used to collect descriptive information about types and sources of information that caregivers desire in relation to their child's diagnosis.

up to 4 weeks before and 2 weeks after intervention
Child Adjustment and Parent Efficacy Scale
Time Frame: up to 4 weeks before and 2 weeks after intervention

The Child Adjustment and Parent Efficacy Scale (CAPES; Morawska & Sanders, 2010) includes 50 Likert scale items

This yields two measurements: one for Child Emotional and Behavioral Problems and one for Parent Efficacy.

Child Emotional and Behavioral Problems: Minimum score = 0; Maximum score = 81. Higher scores indicate greater levels of child problems.

Parent Efficacy: Minimum score = 19; Maximum score = 190 Higher scores indicate greater levels of parent self-efficacy.

up to 4 weeks before and 2 weeks after intervention
Parenting Stress Index, Fourth Edition Short Form
Time Frame: up to 4 weeks before and 2 weeks after intervention
The Parenting Stress Index, Fourth Edition Short Form (PSI-4-SF; Abidin, 2012)includes 36 items. Minimum score = 36; Maximum score = 180. Higher scores indicate higher parent stress levels.
up to 4 weeks before and 2 weeks after intervention
Family Support Scale
Time Frame: up to 4 weeks before and 2 weeks after intervention

The Family Support Scale (FSS; Dunst, et al., 1984)includes 18 Likert scale items.

Minimum score = 0 Maximum score = 95 Higher scores indicate more family support.

up to 4 weeks before and 2 weeks after intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weekly Support Group Attendance
Time Frame: throughout intervention, up to 8 weeks.
We track individual attendance at each support group meeting. Minimum score is 1 and maximum score is 8. The maximum score indicates full participation in all meetings.
throughout intervention, up to 8 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amanda Van Horne, PhD, University of Delaware

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 20, 2026

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

June 15, 2026

Study Registration Dates

First Submitted

March 12, 2026

First Submitted That Met QC Criteria

April 10, 2026

First Posted (Actual)

April 17, 2026

Study Record Updates

Last Update Posted (Actual)

April 17, 2026

Last Update Submitted That Met QC Criteria

April 10, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The ICPSR (Inter-university Consortium for Political and Social Research) data repositories and data management standards apply here. In all cases, we offer participants the chance to opt out of data sharing. The following applies to those who agree to data sharing. For focus groups and participant interviews which cannot be fully de-identified, we will share redacted transcripts with individuals with an IRB with access managed by ICPSR. For pre/post measures and daily surveys of participation, we will share de-identified data sets.

IPD Sharing Time Frame

Deidentified IPD data will be shared 1 year after the study is completed or when the grant ends, which ever is first and will be available in perpetuity on clinical trials.gov. Focus group and structured interviews will be deposited in ICPSR at that time.

IPD Sharing Access Criteria

To access data from ICPSR, users must present an approved IRB that justifies access consistent with participant's initial consent process and honors participant privacy and confidentiality.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Developmental Language Disorder

Clinical Trials on Support Groups

Subscribe